av/innate-pharma-sa--big.svg

NASDAQ:IPHA

Innate Pharma S.A.

  • Stock

USD

Last Close

1.93

02/05 08:31

Market Cap

163.52M

Beta: 0.32

Volume Today

18.96K

Avg: 17.77K

PE Ratio

−1.87

PFCF: −9.30

OverviewFinancialsAPI

    Description

    Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.8-0.6-0.4-0.22019-09-132020-12-312022-06-302023-11-142024-05-10

    Revenue (Estimate*)

    10M20M30M40M2019-09-132020-12-312022-06-302023-11-142024-05-10

    *Estimate based on analyst consensus